Hims & Hers Chief Legal Officer Sells Shares Under Pre-Set Trading Plan
Soleil Boughton, Chief Legal Officer of Hims & Hers Health (NYSE: HIMS), sold 6,236 shares in a transaction valued at $173,735. The sale was conducted under a Rule 10b5-1 trading plan established on May 21, 2026, which allows insiders to execute trades based on pre-determined instructions. This structured approach suggests the sale is part of routine portfolio management rather than an indication of distress or negative sentiment about company prospects. Following this transaction, Boughton still holds a significant stake in Hims & Hers Health, with 304,270 shares valued at approximately $8.5 million as of September 16, 2026. The stock has experienced a challenging period, down nearly 50% over the past year and declining by more than 13% in 2026 alone. Despite these declines, Hims & Hers Health remains a major player in digital health with $2.6 billion in trailing twelve-month revenue.
Tickers: $HIMS